IBM, Five9 to provide evidence-backed cancer treatment AI

Wednesday, Dec 13, 2017 11:10

The signing ceremony between IBM and Five9 to implement IBM Watson for Oncology in Viet Nam. — Photo

IBM and Five9 on Tuesday announced their partnership to implement IBM Watson for Oncology – the first artificial intelligence (AI) - driven oncology clinical decision support system that helps doctors advance cancer care for patients – in Viet Nam.

Phu Tho Hospital will be the first in Viet Nam to adopt IBM Watson for Oncology.

According to Nguyen Trong Huan, director of software provider Five9, IBM Watson for Oncology provides clinicians with confidence-ranked treatment options and supporting evidence to help them make treatment decisions for their patients.

With IBM Watson for Oncology, trained by New York-based Memorial Sloan Kettering Cancer Centre, one of the world’s leading cancer centres, physicians can quickly identify key information related to the patient’s medical record, find relevant evidence and explore treatment options.

Huan said profits from implementing IBM Watson for Oncology would be used to support patients using this system.

According to the company, IBM Watson for Oncology is being used by some 80 hospitals in 11 countries.

It is now available to assist clinicians on breast, lung, colon and rectal, as well as gastric, ovarian, cervical and prostate cancers.

Nguyen Viet Tien, deputy minister of health, said IBM Watson for Oncology marked a new step in applying information technology in cancer treatment in Viet Nam to enhance quality of healthcare services. — VNS

Comments (0)